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Introduction
Nitric oxide (NO) has been shown to be of signiﬁ-
cance and relevance for short and long term regula-
tion of myocardial function and gene expression.
The ﬁrst evidence that NO may inﬂuence myocyte
function resulted from observations of changes in
myocardial contractility by the release of various
transmitters of the endocard or endothelium [41, 42].
NO and other substances which increase the intra-
cellular cGMP level, decreased the systolic tension in
single myocytes, muscle strips and isolated hearts.
Simultaneously, single contraction parameters, espe-
cially contraction time, were also altered. The accel-
eration in relaxation time was the main reason for the
signiﬁcant shortening of the contraction time [20, 35,
37, 42].
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j Abstract Nitric oxide (NO) has inﬂuence on various cellular functions.
Little is known of the inﬂuence of NO on myocardial energetics. In the
present study oxygen consumption and mechanical parameters of
isometrically contracting rabbit papillary muscles (1 Hz stimulation
frequency) were investigated at varying interventions while maintaining
physiological conditions (37 C; 2.5 mM Ca
2+) to study the effects of NO
on energetics. The NO donor sodium nitroprusside (SNP) showed a
negative inotropic effect. SNP decreased the maximal force in normal
rabbit muscle strips by 30%, the force time integral (FTI) by 40% and the
relaxation time by 20%. In addition the oxygen consumption decreased
by 60%, a notably disproportional decrease compared to the mechanical
parameters. Consequently, the economy as a ratio of FTI and oxygen
consumption is signiﬁcantly increased by SNP. In contrast the negative
inotropic effect due to a reduction in extracellular Calcium (Ca
2+) from
2.5 to 1.25 mM reduced FTI and oxygen consumption proportionally by
40% and did not change economy. The effect of NO on force and oxygen
consumption could be reproduced by the application of the cyclic
guanosine monophosphate (cGMP) analogue 8-bromo-cGMP. In sum-
mary, NO increased the economy of isometrically contracting papillary
muscles. The improvement in contraction economy under NO seems to
be mediated by cGMP as the secondary messenger and maybe due to
alterations of the crossbridge cycle.
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inﬂuence the effects of b-adrenergic stimulation.
Several experiments have shown that the positive
inotropic effect of isoprenaline was signiﬁcantly
decreased in the presence of NO [1, 39, 46, 47].
This effect is nearly eliminated by the inhibition of
NO-synthases through L-NMMA.
The inﬂuence of NO on myocardial inotropic,
chronotropic and dromotropic response seems to be
biphasic [36]. Kojda et al. [15] observed that isolated
ventricular rat myocytes exhibited a small, however
signiﬁcant positive inotropic reaction as well as an
elevated isoprenaline effect under a small concentra-
tion of the NO-donor S-Nitroso-N-Acetyl Penicill-
amin (SNAP). In the same experiment higher doses of
SNAP decreased maximal systolic tension.
The endocardium plays an important role in the
regulation of the myocardial function by NO. Fort
et al. [5] showed that the intraventricular infusion of
SNP at any concentration into hearts without endo-
cardium had no effect on maximal tension and
relaxation time. However, if SNP was added to coro-
nary arteries with endothelium, the left ventricular
tension decreased and the relaxation time was short-
ened. Moreover, in papillary muscles isolated from
pigs with the endocardium removed, SNP showed a
positive inotropic outcome. These ﬁndings validate
the inﬂuence of endocardium or respectively endo-
thelium on the decrease in systolic tension and
shortened relaxation time in myocardium.
The observed changes in muscle mechanics led to
the supposition that NO may inﬂuence the oxygen
consumption as well as energetics of myocardium. To
identify the effects of NO on energetics we investi-
gated the inﬂuence of the NO donor SNP on papillary
muscle contractions and oxygen consumption. The
effects of NO were compared with the effects of cGMP
as well as with a change in extracellular Ca
2+ con-
centration.
Methods
j Papillary muscle preparation
Animal handling was reviewed and approved by the
Animal Investigation Committee of the University of
Goettingen. Right ventricular papillary muscles were
gathered from New Zealand White rabbits (2.2–2.8 kg
body weight). Immediately after cardiectomy, the
heart was removed and submerged in cold (4 C)
protective solution bubbled with 95% O2 and 5% CO2
(Carbogen). The solution contained (mmol/l) Na
+
152, K
+ 3.6, Cl
) 135, HCO3
) 25, Mg
2+ 0.6, H2PO4
) 1.3
SO4
2) 0.6 Ca
2+ 2.5, glucose 11.2 and 2,3-butanedione
monoxime (BDM) 30 along with 10 IU/l insulin
(Hoechst, Inc). All chemicals were purchased from
Sigma (Sigma, Inc) unless otherwise indicated. This
protective solution was shown to preserve myocar-
dium during transportation and dissection and to be
completely reversible after washout [24]. Ventricles
were gently rinsed to clear remaining blood. Prepa-
ration of myocardium was performed in a dissection
chamber ﬁlled with the protective solution. Right
ventricular papillary muscles were abscised at the
base from the ventricular wall. Only long, cylindrical
muscles were used.
j Experimental protocol
Papillary muscles were placed into the measurement
apparatus (Muscle Research System, Scientiﬁc
Instruments, Heidelberg, Germany) and clamped at
both ends. The muscles were perfused with Krebs-
Ringer solution (composition as above without BDM)
bubbled with Carbogen and warmed to 37 C. Hepes
Buffer with a concentration of 5 mmol/l at a pH of 7.4
was used in addition to the Krebs solution during the
SNP experiments. Isometric contraction was accom-
plished by stimulation with a 5 ms pulse applied end-
to-end at a voltage 25% above threshold and a fre-
quency of 1 Hz. After an equilibration period of
30 min, muscles were stretched in 0.05 mm incre-
ments until additional stretch did not produce an
increase in developed force. This length was taken as
lmax. Mechanical parameters (twitch tension and
timing parameters) and oxygen consumption were
measured at steady state conditions. Dose–response
experiments were performed with incremental doses
of SNP and 8-bromo cGMP in each muscle prepara-
tion.
Isometric force was acquired digitally from the
force transducer (KG4, Scientiﬁc Instruments).
Twitch tension was deﬁned as the active tension
developed during the isometric twitch. Force-time
integral was calculated as the area under the twitch
force curve. At the end of each experiment muscle
length and weight were measured. Cross-sectional
area for normalization of force values was calculated
as the ratio of blotted muscle weight to muscle length
(lmax).
j Oxygen consumption
The method used to measure oxygen consumption
was described and validated previously [21]. Brieﬂy, a
miniature oxygen electrode continuously measured
PO2 in the experimental chamber close to the muscle
surface. The drop in PO2 at the probe tip was mea-
sured over 20 s and compared to precalculated theo-
retical proﬁles to determine the rate of oxygen
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  Steinkopff Verlag 2009consumption of the muscle (mVO2). Economy was
calculated at each concentration of SNP and cGMP as
the ratio of FTI to oxygen consumption.
j Statistics
All results are reported as means ± SD unless other-
wise noted. Comparisons between NO treated and
control muscles were performed by unpaired t test or
one-way ANOVA with a Tukey adjustment for mul-
tiple comparisons. A P value < 0.05 was considered
signiﬁcant for all tests.
Results
Dose–response experiments in 8 isometrically con-
tracting papillary muscles from different animals were
performed at 10
)5,1 0
)4, and 10
)3 M SNP. Active
tension and FTI both decreased continuously with
maximum depressions of 29 ± 3% and 36 ± 3%
respectively at 10
)3 M SNP (P < 0.01) compared to
control conditions at 2.5 mM free calcium (Fig. 1)
while diastolic tension remained unchanged. Consis-
tent with previous experiments [27] SNP signiﬁcantly
decreased the time from peak twitch tension to 90%
relaxation (RT90) by 20 ± 5% (P < 0.01). In addition,
maximal relaxation velocity ()dT/dt) increased by
20 ± 7% (P < 0.05). Time to peak tension (TTPT) and
maximal velocity of force rise (+dT/dt) were not
found to be signiﬁcantly altered (Fig. 2).
The free calcium concentration of the Krebs–
Ringer solution was halved from 2.5 to 1.25 mmol/l to
compare the observed negative inotropic effects of
SNP. This intervention resulted in a 50 ± 3% decrease
in active force (P < 0.01) and a 37 ± 6% decrease in
FTI (P < 0.01) (Fig. 1). Time to peak tension, +dT/dt
and relaxation parameters were not affected (Fig. 2).
Muscle preparations showed a concentration depen-
dent decrease in oxygen consumption with maximal
reduction of 55 ± 4% being reached at 10
)3 MS N P
(P < 0.01). Halving the free calcium concentration
resulted in a 40 ± 6% decrease of oxygen consumption
(P < 0.01) (Fig. 3). Though basal oxygen consumption
under SNP and calcium did not differ (P =N S ) .
Economy as a ratio of FTI to oxygen consumption
increased under rising SNP concentrations up to
140 ± 9% (SNP 10
)3 M; P < 0.01). However, the
change in free calcium concentration did not show a
signiﬁcant difference in economy (P = NS) (Fig. 4).
To investigate the possible role of increased
intracellular cGMP levels through SNP, mechanical
parameters and oxygen consumption were measured
in another eight papillary muscle preparations.
Increasing concentrations of 8-bromo cGMP (10
)6,
10
)5 and 10
)4 M) were added to the Krebs–Ringer
solution. Twitch force and FTI decreased continuously
with increasing cGMP concentrations. At 10
)4 M8 -
bromo cGMP twitch force and FTI reached were mini-
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Fig. 1 Original registration of a representative experimental chart. Duplication
of calcium from 1.25 to 2.5 mM increased force by 100%. Treatment with
sodium nitroprusside decreased maximal force by 30%
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Fig. 2 Representative twitches of right ventricular
papillary muscles. Records show twitches at1.25 and
2.5 mmol/l calcium and 10
)3 mol/l sodium nitro-
prusside (SNP). Halving the calcium concentration
decreased force by 50%. Other mechanical
parameters were not effected. Treatment with SNP
reduced maximal force by 30% and accelerated
muscle relaxation
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tively(bothP < 0.01).ConsistentwithSNPexperiments
RT90 was reducedby19 ± 4%and )dT/dt increased by
26 ± 7% (both P < 0.05). TTPT and +dT/dt were not
affected. Halving of free calcium in the Krebs–Ringer
solution showed similar results as described above
(twitch force )47 ± 4%, FTI )42 ± 6%, no change in
TTPT and relaxation parameters).
Oxygen consumption of cGMP treated muscle
preparations decreased by 56 ± 3% (P < 0.005)
whereas the halving of calcium resulted in a 43 ± 5%
reduction (P < 0.005) (Fig. 3). Therefore, the econ-
omy for cGMP treated muscles increased by 40 ± 8%
(P < 0.01) while the change in calcium concentration
had no inﬂuence on economy (P = NS) (Fig. 4).
Discussion
In the present study SNP had a negative inotropic
effect in isolated papillary muscles. These results are
consistent with studies done in guinea pigs [2], cats
[22, 23] and clinical studies with intracoronary infu-
sion of SNP in humans [27]. The additionally de-
scribed shortening of contraction time and the
acceleration of relaxation could also be reproduced [7,
27]. However, some authors [2] observed no signiﬁ-
cant changes of the relaxation parameters or con-
traction time in guinea pig hearts. Species and tissue
differences could be responsible for these differences.
The negative inotropic effect of SNP was associated
with a disproportionate decrease in oxygen con-
sumption as compared to the proportional decrease
in active force and oxygen consumption induced by
reducing the Ca
2+ concentration from 2.5 to 1.25 mM.
As a consequence contraction economy increased
with SNP whereas halving the calcium concentration
had no inﬂuence on myocardial energetics.
The participation of NO in the ischemic precon-
ditioning cell-survival program is widely discussed in
the literature. Previous studies [17, 18, 40] indicated
that endothelium-derived NO is an important regu-
lator of tissue oxygen consumption in myocardium in
vivo and vitro. The mechanisms underlying cytopro-
tection involve the modulation of mitochondrial
function such as reversal inhibition of cytochrome c
oxidase and a reduction of mitochondrial enzyme
activities including aconitase in the Krebs cycle and
complex I and II of the mitochondrial electron
transport chain.
Peroxinitrate, formed by the interaction of NO
with superoxide, also promotes a suppression of
respiration [43]. However, the inhibition of cellular
respiration by peroxinitrate is not reversible. Thus, it
is unlikely to act as a potent physiological regulator
for tissue oxygen consumption.
Additionally, Rickover et al. [34] described a SNP
triggered activation of the sarcoplasmic calcium-
ATPase with increased Ca
2+ uptake into the sarco-
plasmic reticulum and thus prevention of cytosolic
Ca
2+ overload in rat cardiomyocytes. The overpro-
portional decrease of oxygen consumption and in-
crease in contraction economy after SNP treatment
observed in our study may result from effects on
calcium cycling and be part of the beneﬁcial effects of
NO during ischemia/reperfusion when oxygen is
limiting and tissue becomes acidotic and may en-
hance ischemic tolerance during preconditioning.
Moreover, NO has been shown to control substrate
utilization of myocytes [33, 45]. Lack of NO causes
preferential utilization of carbohydrates by myocar-
dium. This deﬁcit may be important especially in
heart failure and diabetes when NO production by
blood vessels is reduced or abolished. Recchia [32]
hypothesized that prevalent carbohydrate utilization
might be advantageous for the heart because the ATP
yield from carbohydrate oxidation is greater for a
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Fig. 3 Oxygen consumption normalized to 2.5 mmol/l calcium as control. SNP,
sodium nitropsusside; cGMP, cyclic guanosine monophosphate; *Statistically
significant decrease in oxygen consumption
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Fig. 4 Economy normalized to 2.5 mmol/l calcium as control. SNP, sodium
nitroprusside, cGMP, cyclic guanosine monophosphate; *Statistically significant
increase of economy
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ATP/oxygen ratio compared to that of free fatty acid
oxidation. Switching from free fatty acid to lactate can
result in a reduction of around 10% of oxygen con-
sumption [30]. However, healthy hearts in the fasting
state consume primarily fatty acids, because this is
their optimal substrate. The shift to prevalent carbo-
hydrate utilization by the failing heart likely repre-
sents an adaptive response to face profoundly altered
mechanics and energy turnover e.g. increased basal
oxygen consumption and reduced efﬁciency, even if it
could be disadvantageous in the long-term.
To further investigate the role of NO on subcellular
mechanisms in myocytes, the membrane permeable
cGMP-analogue 8-bromo cGMP was used. Through
experimentationitwasdeterminedthat8-bromocGMP
producedsimilarresultstoSNPatonlyonetenthofthe
SNP concentration. These ﬁndings suggest that the ef-
fects of NO on myocytes are primarily mediated by
cGMP and consistent to recent studies [16].
Guanylate cyclase is stimulated by extracellular NO
and synthesizes cGMP from guanosine triphosphate
(GTP). Within the myocardial cells cGMP and cyclic
adenosine monophosphate (cAMP) are antagonists.
Previous studies described dose dependent effects on
contractile function of cGMP or rather NO [15, 31].
On one hand very low NO concentrations increase
intracellular cAMP levels by activation of adenylyl
cyclases directly [14] and by a cGMP-mediated inhi-
bition of phosphodiesterase [29, 35] with a conse-
quently diminished breakdown of cAMP. This leads
to phosphorylation and thus activation of the L-type
calcium channel and other key proteins in calcium
cycling [38, 44]. Therefore, calcium inﬂux and cal-
cium transients are increased in myocytes resulting in
an increase in contractile function but also myocar-
dial oxygen consumption. Moreover, positive inotro-
pic effects of low-dose NO are possible by increasing
contractile calcium responsiveness [10]. On the other
hand high NO concentrations activate a cGMP
dependent cAMP phosphodiesterase with consequent
reduction in cAMP concentrations [4, 35]. Addition-
ally, the cAMP phosphorylated L-type calcium chan-
nel is dephosphorylated by cGMP dependent
phosphatase(s) [38] and troponin I and phospho-
lamban are phosphorylated [13, 16]. Phosphorylation
of troponin I reduces the calcium sensitivity of the
thin ﬁlament by a decrease of the afﬁnity of troponin
C to calcium and ampliﬁes the loss in tension [12, 16,
25]. Evidence that high cGMP concentrations cause a
negative inotropic effect was shown by extracelluar
application of acetylcholine [6]. In other experiments
with similar results a cGMP-analogue was used [35].
Moreover, phosphorylated troponin I prevents cal-
cium-independent diastolic cross-bridge cycling [26].
Phosphorylation of phospholamban activates the
sarcoplasmic calcium-ATPase and thereby accelerates
calcium elimination out of the cytosol [28]. A further
decrease in systolic and diastolic force and additional
shortening of contraction time would result. The de-
scribed effects are in agreement with our ﬁndings of a
shortened relaxation time and an increase in relaxa-
tion velocity. However, consistent with previous
experiments [11] there was no signiﬁcant change in
diastolic force generation assuming that diastolic
stiffness is negligible in nonfailing rabbit myocardium
in contrast to patients with dilated cardiomyopathy or
aortic stenosis.
Thus, the negative inotropic effect of SNP observed
in our experiments may be caused by dephosphoryl-
ation of the L-type calcium channel, a decreased
cAMP concentration in the cell, an accelerated cal-
cium uptake in the sarcoplasmic reticulum or a shift
in thin ﬁlament calcium sensitivity.
The mechanism behind the improvement of the
contraction economy is not clear. Economy
improvement may be due to the increases in economy
of ATP synthesis or a reduction of ATP usage per unit
of developed tension. Animal models have shown that
under special experimental conditions NO reduces the
ATP synthesis in mitochondria [3]. However, basal
oxygen consumption under NO and control condi-
tions did not differ in our experiments, suggesting the
economy of ATP synthesis remained unchanged (data
not shown). Due to technical reasons high solution
oxygen partial pressures are needed in the diffusion
method. Therefore, effects of super-physiological
oxygen partial pressures on mitochondria NO inter-
actions and NO metabolism can not be excluded and
may have an impact on the observed results.
A reduction of ATP usage per unit of developed
tension may be a result of changes in excitation-
contracting coupling or myoﬁbrillar performance.
Both require energy during the contraction-relaxation
cycle [19]. Given that excitation-contracting coupling
requires 15–20% of the total ATP used [8], it is un-
likely that the demonstrated improvement in con-
traction economy is based on effects on excitation-
contracting coupling alone. Moreover, decreased cal-
cium sensitivity by phosphorylation of troponin I
may rather increase energy consumption for calcium
cycling [12, 25]. Therefore, a major reduction of ATP
usage seems to be caused by improved economy at
the level of myoﬁbrillar proteins. The underlying
mechanism may be an increase in the FTI of a single
cross-bridge through a lengthened thin ﬁlament
attachment time to myosin. A corresponding change
of cross-bridge economy was demonstrated with
some calcium sensitizers [9] as well as in hypertro-
phic and insufﬁcient myocardium [8]. This effect
caused by NO is most likely responsible for the
improvement in contraction economy.
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Effects of NO on energetics in myocardiumThe more pronounced decrease in oxygen con-
sumption relative to FTI and therefore the increase in
economy of isolated papillary muscle preparations
after SNP treatment may be part of the improvement
observed in nitrate treated patients with coronary
heart disease.
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